Neuphoria Therapeutics Inc. ( NEUP) - Stock Earnings
NEUP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.9 million USD | — USD |
| 2026Q1 | -505063 USD | — USD |
| 2026Q2 | -4.9 million USD | 1.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NEUP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -15.5 million USD | — USD |
| 2025 | -369632 USD | 15.6 million USD |
| 2026 | -13.5 million USD | 1.2 million USD |
| 2026 Est. | — | — |
NEUP
Price: $3.48
52 week price:
Earnings Per Share: -3.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 18.2 million